SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer (Q27824786)
scientific article
Language:
(P31) (Q13442814)
(P304) 630-4
(P407) (Q1860)
(P433) 6
(P478) 87
(P577) Monday, September 9, 2002
(P921) (Q974135)
(Q181600)
(Q188874)
(Q25493920)
(P1433) (Q326309)
(P1476) "SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer" (language: en)
(P2093) J L Boulay
G Mild
A Lowy
J Reuter
M Lagrange
L Terracciano
U Laffer
R Herrmann
C Rochlitz
(P2860) (Q22065842)
(Q24315119)
(Q24319995)
(Q28032484)
(Q28143408)
(Q28363159)
(Q28281575)
(Q28251743)
(Q28281200)
(Q29616726)
(Q34607080)
(Q36618842)
(Q36302971)
(Q40899125)
(Q41151156)
(Q29036482)
(Q36404409)
(Q33964215)
(Q35726298)
(Q41732765)
(Q48058869)
(Q53445992)
(Q45192274)
(Q78159554)
(Q73969923)
(Q72024722)
(Q72519129)
(Q71167724)
(Q74606005)
other details